Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.

about

Continued Interest and Controversy: Vitamin D in HIV.

P2860

Q54224147-F5ACE3C1-CCA6-4C5E-934F-A585FB3D99E9

P2860

Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.

Item

http://www.wikidata.org/entity/Q40563423

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prevalence and risk factors fo ...... y: A prospective cohort study.

@en

type

Item

label

Prevalence and risk factors fo ...... y: A prospective cohort study.

@en

prefLabel

Prevalence and risk factors fo ...... y: A prospective cohort study.

@en

P1476

Prevalence and risk factors fo ...... y: A prospective cohort study.

@en

P2093

Abiy Habtewold

http://www.w3.org/2001/XMLSchema#string

Eyasu Makonnen

http://www.w3.org/2001/XMLSchema#string

Hanna Nylén

http://www.w3.org/2001/XMLSchema#string

Jürgen Burhenne

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients

Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes

25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings

No evidence for induction of ABC transporters in peripheral blood mononuclear cells in humans after 14 days of efavirenz treatment.

Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy

McCollum Award Lecture, 1994: vitamin D--new horizons for the 21st century.

Vitamin D intake: a global perspective of current status.

P304

e4631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000004631

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27559961

http://www.w3.org/2001/XMLSchema#string

P921

vitamin deficiency

vitamin D deficiency

P932

5400328

http://www.w3.org/2001/XMLSchema#string

Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.

about

P2860

P2860

Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932